跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
VARILRIX HSA-FREE varicella vaccine live attenuated 0.5mL powder for injection vial - TGA Drug Approval Details
Approvals
/
TGA
/
VARILRIX HSA-FREE varicella vaccine live attenuated 0.5mL powder for injection vial
Approved
STANDARD
VARILRIX HSA-FREE varicella vaccine live attenuated 0.5mL powder for injection vial
GlaxoSmithKline Australia Pty Ltd
🇦🇺 Therapeutic Goods Administration
Approval Date
Dec 9, 2025
Approval ID
7663629e3f584b4d
Company
GlaxoSmithKline Australia Pty Ltd
Type
Standard
Approval Details
Approval Id
7663629e3f584b4d
Product Name
VARILRIX HSA-FREE varicella vaccine live attenuated 0.5mL powder for injection vial
Artg Id
234752
Artg Name
VARILRIX HSA-FREE varicella vaccine live attenuated 0.5mL powder for injection vial
Sponsor
GlaxoSmithKline Australia Pty Ltd
Company Detail Path
/organization/glaxosmithkline-australia-pty-ltd
Artg Date
2015-04-16
Registration Type
Medicine
Therapeutic Good Type
Medicine
Licence Status
A
Licence Category
RE
Consumer Medicine Info
https://medical-cdn.nocode.com/drug_tga/b1fc7db7513f54de786cd7f9094d1c7e.pdf
Product Information
https://medical-cdn.nocode.com/drug_tga/0de6d8d837ce6264b4875d80641fe77b.pdf
Approved
Quick Info
Agency
TGA
Country
🇦🇺
Approval Date
Dec 9, 2025
Approval ID
7663629e3f584b4d
Type
Standard
Back to TGA Approvals